Medline goes public at $29 a share in 2025’s largest global IPO, raising $6.26 billion. The company sells 216 million shares, granting a 32.4 million share greenshoe option. Proceeds will reduce $4 billion of debt and provide liquidity to pre-IPO owners. Medline’s massive healthcare supply-chain business spans 69 facilities and 2,000 trucks. Investors watch margins, tariffs, and market debut closely.